Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
NCT02386839
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinopathy of Prematurity (ROP)
Interventions
DRUG:
rhIGF-1/rhIGFBP-3
Sponsor
Shire